Compile Data Set for Download or QSAR
Report error Found 20 Enz. Inhib. hit(s) with all data for entry = 12864
TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734458(US20250129068, Example 17)
Affinity DataKi:  2.28nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734438(US20250129068, Example 4)
Affinity DataKi:  2.49nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734457(US20250129068, Example 16)
Affinity DataKi:  4.19nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734452(US20250129068, Example 13)
Affinity DataKi:  4.42nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734440(US20250129068, Example 5)
Affinity DataKi:  5.78nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734446(US20250129068, Example 9)
Affinity DataKi:  6.60nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734451(US20250129068, Example 12)
Affinity DataKi:  7.76nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734450(US20250129068, Example 11)
Affinity DataKi:  8.17nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734459(US20250129068, Example 18)
Affinity DataKi:  8.83nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734455(US20250129068, Example 14)
Affinity DataKi:  17.8nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734442(US20250129068, Example 6)
Affinity DataKi:  29.3nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734445(US20250129068, Example 8)
Affinity DataKi:  59.9nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734460(US20250129068, Example 19)
Affinity DataKi:  65nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734461(US20250129068, Example 20)
Affinity DataKi:  67nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734436(US20250129068, Example 2)
Affinity DataKi:  107nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734456(US20250129068, Example 15)
Affinity DataKi:  124nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734444(US20250129068, Example 7)
Affinity DataKi:  127nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734437(US20250129068, Example 3)
Affinity DataKi:  128nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734435(US20250129068, Example 1)
Affinity DataKi:  172nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent

TargeteIF-2-alpha kinase GCN2(Human)
IP2IPO Innovations

US Patent
LigandPNGBDBM734448(US20250129068, Example 10)
Affinity DataKi:  209nMAssay Description:The inhibitory activity of the Example compounds towards GCN2 enzyme was measured according to the description below, using a LanthaScreen TR-FRET (T...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/25/2025
Entry Details
US Patent